Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks
-
Trump in Epstein files: five takeaways from latest release
-
Wasteful Nigeria open AFCON campaign with narrow win over Tanzania
-
Ukraine retreats in east as Russian strikes kill three, hit energy
-
Macron meets French farmers in bid to defuse anger over trade deal
-
Ineos snap up Scotsman Onley
-
UK comedian Russell Brand faces new rape, assault charges: police
-
World is 'ready' for a woman at helm of UN: Chile's Bachelet tells AFP
-
Real Madrid's Endrick joins Lyon on loan
-
Latest Epstein files renew scrutiny of Britain's ex-prince Andrew
-
US consumer confidence tumbles in December
-
Norwegian biathlete Sivert Guttorm Bakken found dead in hotel
-
UK comedian Russell Brand faces two new rape, assault charges: police
-
Venezuela seeks to jail backers of US oil blockade
-
Norwegian biathlete Sivert Guttorm Bakken found dead
-
Wall Street stocks edge higher
-
Vietnam Communist Party endorses To Lam to stay in top job
-
US economic growth surges in 3rd quarter, highest rate in two years
-
Frank defends Van de Ven after Slot slams 'reckless' foul on Isak
-
Russian paramilitaries in CAR say take election threat 'extremely seriously'
-
Trump in the Epstein files: five takeaways from latest release
-
UK govt to relax farmers inheritance tax after protests
-
Pakistani firm wins auction for state airline PIA
-
Stocks slip on strong US growth data
-
DR Congo beat Benin to kick off Cup of Nations bid
-
New Epstein files dump contains multiple Trump references
-
Russian strike could collapse Chernobyl shelter: plant director
-
Springbok captain Kolisi to rejoin Stormers
-
Italy fines Ryanair $300 mn for abuse of dominant position
-
Mahrez eyes strong AFCON showing from Algeria
-
Killer in Croatia school attack gets maximum 50-year sentence
-
Thousands of new Epstein-linked documents released by US Justice Dept
-
Stocks steady as rate cut hopes bring Christmas cheer
-
Bangladesh summons Indian envoy as protest erupts in New Delhi
-
Liverpool's Isak faces two months out after 'reckless' tackle: Slot
-
Thailand-Cambodia border meeting in doubt over venue row
-
For director Josh Safdie, 'Marty Supreme' and Timothee Chalamet are one and the same
-
Kyiv's wartime Christmas showcases city's 'split' reality
-
Gazans fear renewed displacement after Israeli strikes
-
Locals sound alarm as Bijagos Islands slowly swallowed by sea
-
Markets mostly rise as rate cut hopes bring Christmas cheer
-
Cambodia asks Thailand to move border talks to Malaysia
-
In Bulgaria, villagers fret about euro introduction
-
Key to probe England's 'stag-do' drinking on Ashes beach break
-
Delayed US data expected to show solid growth in 3rd quarter
-
Thunder bounce back to down Grizzlies, Nuggets sink Jazz
-
Amazon says blocked 1,800 North Koreans from applying for jobs
-
Trump says US needs Greenland 'for national security'
-
Purdy first 49er since Montana to throw five TDs as Colts beaten
-
Australia captain Cummins out of rest of Ashes, Lyon to have surgery
-
North Korea's Kim tours hot tubs, BBQ joints at lavish new mountain resort
NYSE - LSE
Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks
LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 8, 2025 / Renovaro Inc. (NASDAQ:RENB) was referenced in a recent RealClearDefense article titled "AI Can Be Used to Develop Biological and Chemical Weapons", which examines the complex challenges posed by artificial intelligence in the context of global security and biodefense.
The full article can be accessed at: https://www.realcleardefense.com/articles/2025/08/07/ai_can_be_used_to_develop_biological_and_chemical_weapons_1127450.html
Renovaro's inclusion reflects its growing role in advancing responsible innovation at the intersection of AI, counter bioterrorism, and national preparedness. The company's strategic focus includes the development of precision neurology platforms and AI-enhanced countermeasures designed to detect, mitigate, and respond to emerging biological threats.
Commenting on the company's recently announced countermeasure initiative, CEO David Weinstein stated:
"We believe the convergence of AI and biotechnology demands not only innovation, but moral clarity. Our countermeasure initiative is designed to anticipate and neutralize biological threats before they escalate - while reinforcing cognitive resilience and operational integrity in those on the front lines. Renovaro is committed to building technologies that protect life and uphold trust."
Renovaro continues to engage with regulators, researchers, and strategic partners to ensure its platforms meet the highest standards of safety, transparency, and ethical deployment. The company views its mention in RealClearDefense as part of a broader recognition of the urgent need for leadership in biodefense innovation.
About Renovaro (NASDAQ: RENB)
Renovaro Inc. (NASDAQ: RENB) is building category-defining AI-driven platforms for precision medicine, diagnostics, and biodefense. Its proprietary technologies transform complex biomedical data into predictive insights, enabling faster discovery, greater accuracy, and strategic partnerships across the life sciences and government sectors.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking and subject to risks and uncertainties that could cause actual results to differ materially. Please refer to our filings with the SEC for a discussion of these risks.
Contact:
[email protected]
www.renovarogroup.com
SOURCE: Renovaro Biosciences
View the original press release on ACCESS Newswire
D.Johnson--AT
